Skip to main content
Top
Published in: BMC Neurology 1/2007

Open Access 01-12-2007 | Research article

Pattern of neuropsychological performance among HIV positive patients in Uganda

Authors: Kevin R Robertson, Noeline Nakasujja, Matthew Wong, Seggane Musisi, Elly Katabira, Thomas D Parsons, Allan Ronald, Ned Sacktor

Published in: BMC Neurology | Issue 1/2007

Login to get access

Abstract

Background

Few studies have examined cognitive functioning of HIV positive patients in sub-Saharan Africa. It cannot be assumed that HIV positive patients in Africa exhibit the same declines as patients in high-resource settings, since there are differences that may influence cognitive functioning including nutrition, history of concomitant disease, and varying HIV strains, among other possibilities. Part of the difficulty of specifying abnormalities in neuropsychological functioning among African HIV positive patients is that there are no readily available African normative databases. The purpose of the current study was to evaluate the pattern of neuropsychological performance in a sample of HIV positive patients in comparison to HIV negative control subjects in Uganda.

Methods

The neuropsychological test scores of 110 HIV positive patients (WHO Stage 2, n = 21; WHO Stage 3, n = 69; WHO Stage 4, n = 20) were contrasted with those of 100 control subjects on measures of attention/concentration, mental flexibility, learning/memory, and motor functioning.

Results

Analysis of covariance (ANCOVA) revealed significant group differences on measures of verbal learning and memory, speed of processing, attention and executive functioning between HIV seropositive and seronegative subjects.

Conclusion

Ugandan patients with HIV demonstrated relative deficits on measures of verbal learning and memory, speed of processing, attention, and executive functioning compared to HIV negative controls. These results from a resource limited region where clades A and D are prevalent are consistent with previous findings in the developed world where clade B predominates.
Literature
1.
go back to reference Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK: Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 1992, 42 (8): 1472-1476.CrossRefPubMed Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK: Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 1992, 42 (8): 1472-1476.CrossRefPubMed
2.
go back to reference Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, et al: Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS. 1993, 7 (5): 669-675. 10.1097/00002030-199305000-00010.CrossRefPubMed Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, et al: Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS. 1993, 7 (5): 669-675. 10.1097/00002030-199305000-00010.CrossRefPubMed
3.
go back to reference Sacktor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002, 8 (Suppl 2): 115-121. 10.1080/13550280290101094.CrossRefPubMed Sacktor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002, 8 (Suppl 2): 115-121. 10.1080/13550280290101094.CrossRefPubMed
4.
go back to reference Saykin AJ, Janssen RS, Sprehn GC, Kaplan JE, Spira TJ, O'Connor B: Longitudinal evaluation of neuropsychological function in homosexual men with HIV infection: 18-month follow-up. J Neuropsychiatry Clin Neurosci. 1991, 3 (3): 286-298.CrossRefPubMed Saykin AJ, Janssen RS, Sprehn GC, Kaplan JE, Spira TJ, O'Connor B: Longitudinal evaluation of neuropsychological function in homosexual men with HIV infection: 18-month follow-up. J Neuropsychiatry Clin Neurosci. 1991, 3 (3): 286-298.CrossRefPubMed
5.
go back to reference Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, et al: The HNRC 500 – neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995, 1 (3): 231-251.CrossRefPubMed Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, et al: The HNRC 500 – neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995, 1 (3): 231-251.CrossRefPubMed
6.
go back to reference McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N: Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003, 9 (2): 205-221.CrossRefPubMed McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N: Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003, 9 (2): 205-221.CrossRefPubMed
7.
go back to reference Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P: Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol. 2005, 11 (3): 265-273. 10.1080/13550280590952790.CrossRefPubMed Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P: Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol. 2005, 11 (3): 265-273. 10.1080/13550280590952790.CrossRefPubMed
8.
go back to reference Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y: Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Archives of Neurology. 1995, 52 (5): 525-530.CrossRefPubMed Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y: Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Archives of Neurology. 1995, 52 (5): 525-530.CrossRefPubMed
9.
go back to reference Benedict RH, Mezhir JJ, Walsh K, Hewitt RG: Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol. 2000, 15 (6): 535-544. 10.1016/S0887-6177(99)00044-X.CrossRefPubMed Benedict RH, Mezhir JJ, Walsh K, Hewitt RG: Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol. 2000, 15 (6): 535-544. 10.1016/S0887-6177(99)00044-X.CrossRefPubMed
10.
go back to reference Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, et al: Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology. 1999, 52 (8): 1640-1647.CrossRefPubMed Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, et al: Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology. 1999, 52 (8): 1640-1647.CrossRefPubMed
11.
go back to reference Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC: Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. Journal of Neurovirology. 2000, 6 (1): 84-88.CrossRefPubMed Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC: Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. Journal of Neurovirology. 2000, 6 (1): 84-88.CrossRefPubMed
12.
go back to reference World Health Organization: '3 by 5' Progress Report. 2004 World Health Organization: '3 by 5' Progress Report. 2004
13.
go back to reference Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD: Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr. 2004, 36 (1): 562-566. 10.1097/00126334-200405010-00003.CrossRefPubMed Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD: Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr. 2004, 36 (1): 562-566. 10.1097/00126334-200405010-00003.CrossRefPubMed
14.
go back to reference Kaleebu P, Whitworth J, Hamilton L, Rutebemberwa A, Lyagoba F, Morgan D, Duffield M, Biryahwaho B, Magambo B, Oram J: Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda. AIDS Res Hum Retroviruses. 2000, 16 (5): 393-401. 10.1089/088922200309052.CrossRefPubMed Kaleebu P, Whitworth J, Hamilton L, Rutebemberwa A, Lyagoba F, Morgan D, Duffield M, Biryahwaho B, Magambo B, Oram J: Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda. AIDS Res Hum Retroviruses. 2000, 16 (5): 393-401. 10.1089/088922200309052.CrossRefPubMed
15.
go back to reference Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B: Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology. 1990, 40 (2): 197-203.CrossRefPubMed Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B: Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology. 1990, 40 (2): 197-203.CrossRefPubMed
16.
go back to reference Maj M, D'Elia L, Satz P, Janssen R, Zaudig M, Uchiyama C, Starace F, Galderisi S, Chervinsky A: Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol. 1993, 8 (2): 123-135. 10.1016/0887-6177(93)90030-5.CrossRefPubMed Maj M, D'Elia L, Satz P, Janssen R, Zaudig M, Uchiyama C, Starace F, Galderisi S, Chervinsky A: Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol. 1993, 8 (2): 123-135. 10.1016/0887-6177(93)90030-5.CrossRefPubMed
17.
go back to reference Rey A: L'examen psychological dans les cas d'encephalopathie traumatique. Archives of Psychology. 1941, 28: 286-340. Rey A: L'examen psychological dans les cas d'encephalopathie traumatique. Archives of Psychology. 1941, 28: 286-340.
18.
go back to reference Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, et al: WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. 1994, 51 (1): 51-61.CrossRefPubMed Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, et al: WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. 1994, 51 (1): 51-61.CrossRefPubMed
19.
go back to reference Dugbartey AT, Townes BD, Mahurin RK: Equivalence of the Color Trails Test and Trail Making Test in nonnative English-speakers. Archives of Clinical Neuropsychology. 2000, 15 (5): 425-431. 10.1016/S0887-6177(99)00034-7.CrossRefPubMed Dugbartey AT, Townes BD, Mahurin RK: Equivalence of the Color Trails Test and Trail Making Test in nonnative English-speakers. Archives of Clinical Neuropsychology. 2000, 15 (5): 425-431. 10.1016/S0887-6177(99)00034-7.CrossRefPubMed
20.
go back to reference Reitan R: Validity of the Trail Making test as an indicator of organic brain damage. Perceptual and Motor Skills. 1958, 8: 271-276.CrossRef Reitan R: Validity of the Trail Making test as an indicator of organic brain damage. Perceptual and Motor Skills. 1958, 8: 271-276.CrossRef
21.
go back to reference Price RW, Brew BJ: The AIDS dementia complex. Journal of Infectious Diseases. 1988, 158 (5): 1079-1083.CrossRefPubMed Price RW, Brew BJ: The AIDS dementia complex. Journal of Infectious Diseases. 1988, 158 (5): 1079-1083.CrossRefPubMed
22.
go back to reference Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N: Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007, 68 (5): 350-355. 10.1212/01.wnl.0000252811.48891.6d.CrossRefPubMed Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N: Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007, 68 (5): 350-355. 10.1212/01.wnl.0000252811.48891.6d.CrossRefPubMed
23.
go back to reference Laeyendecker O, Li X, Arroyo M, McCutchan F, Gray R, Wawer M, Serwadda D, Nalugoda F, Kigozi G, Quinn T, et al: The effect of HIV subtype on rapid disease progression in Rakai, Uganda. 13th Conference on Retroviruses and Opportunistic Infections. 2006, Denver, CO Laeyendecker O, Li X, Arroyo M, McCutchan F, Gray R, Wawer M, Serwadda D, Nalugoda F, Kigozi G, Quinn T, et al: The effect of HIV subtype on rapid disease progression in Rakai, Uganda. 13th Conference on Retroviruses and Opportunistic Infections. 2006, Denver, CO
24.
go back to reference Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E: The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Aids. 2005, 19 (13): 1367-1374.PubMed Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E: The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Aids. 2005, 19 (13): 1367-1374.PubMed
25.
go back to reference Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T: Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc. 2006, 12 (3): 424-430.CrossRefPubMed Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T: Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc. 2006, 12 (3): 424-430.CrossRefPubMed
26.
go back to reference Mindt MR, Cherner M, Marcotte TD, Moore DJ, Bentley H, Esquivel MM, Lopez Y, Grant I, Heaton RK: The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol. 2003, 25 (1): 122-132.CrossRefPubMedPubMedCentral Mindt MR, Cherner M, Marcotte TD, Moore DJ, Bentley H, Esquivel MM, Lopez Y, Grant I, Heaton RK: The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol. 2003, 25 (1): 122-132.CrossRefPubMedPubMedCentral
27.
go back to reference Smith CA, van Gorp WG, Ryan ER, Ferrando SJ, Rabkin J: Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J Acquir Immune Defic Syndr. 2003, 33 (1): 116-118.CrossRefPubMed Smith CA, van Gorp WG, Ryan ER, Ferrando SJ, Rabkin J: Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J Acquir Immune Defic Syndr. 2003, 33 (1): 116-118.CrossRefPubMed
Metadata
Title
Pattern of neuropsychological performance among HIV positive patients in Uganda
Authors
Kevin R Robertson
Noeline Nakasujja
Matthew Wong
Seggane Musisi
Elly Katabira
Thomas D Parsons
Allan Ronald
Ned Sacktor
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2007
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-7-8

Other articles of this Issue 1/2007

BMC Neurology 1/2007 Go to the issue